Impact of diabetes on COVID‐19 and other infection: Report from the 22nd Hong Kong Diabetes and Cardiovascular Risk Factors—East Meets West Symposium

The coronavirus disease 2019 (COVID‐19) pandemic has posed enormous challenges to healthcare systems worldwide. The negative impact of COVID‐19 is widespread and includes not only people who contracted the disease but also those with chronic morbidities such as diabetes whose care is compromised due...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetic medicine 2021-05, Vol.38 (5), p.e14547-n/a
Hauptverfasser: Luk, Andrea O. Y., Ng, Susanna S. S., Holt, Richard I. G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 5
container_start_page e14547
container_title Diabetic medicine
container_volume 38
creator Luk, Andrea O. Y.
Ng, Susanna S. S.
Holt, Richard I. G.
description The coronavirus disease 2019 (COVID‐19) pandemic has posed enormous challenges to healthcare systems worldwide. The negative impact of COVID‐19 is widespread and includes not only people who contracted the disease but also those with chronic morbidities such as diabetes whose care is compromised due to diversion of medical resources. People with diabetes are generally more susceptible to infection as a result of altered immunity. People with diabetes have a worse prognosis from COVID‐19 and there is evidence to suggest that severe acute respiratory syndrome coronavirus 2 may directly affect pancreatic function precipitating hyperglycaemic crises. In the United Kingdom, one of the most heavily affected countries, guidelines are in place to unify the management of people with diabetes hospitalized for COVID‐19. Diabetes services are re‐organized to ensure that medical care of people with diabetes is maintained despite resource and other practical constraints. Public health measures including social distancing, hand hygiene and the use of face masks are crucial in containing community transmission of the virus. Hong Kong, one of the most densely populated city in the world, is particularly vulnerable and has in place a stringent containment policy and aggressive contact tracing to ensure public safety during this pandemic.
doi_str_mv 10.1111/dme.14547
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_33615546</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2492281416</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4437-55c08823dbf9bdf11e142fb0061004120012a0623447a8fcc71ff213348d8c9a3</originalsourceid><addsrcrecordid>eNqNkstu1DAUhi0EosPAghdAltiAUFrfcmOBhDJTOqJVpXJbWo5jty6JHeykaHZ9BBZseL0-CQ4zHQESEl7YRzrf-f0fHwPwGKN9HNdB06l9zFKW3wEzzDKWpKzEd8EM5YwkFOV4DzwI4RIhTEpa3gd7lGY4TVk2Az9WXS_kAJ2GjRG1GlSAzsLq9ONqcXP9DZdQ2Aa64UJ5aKxWcjDOvoRnqnd-gNq7DsYcJCRSR86ew7fTtriVmoor4RvjrkSQYys8PDPhMzyMdzofbq6_L0UY4IlSQ4CfVAzfrbveBTN2D8E9LdqgHm3POfhwuHxfHSXHp29W1evjRDJG8yRNJSoKQptal3WjMVaYEV0jlGGEGCZT0wJlhDKWi0JLmWOtCaaUFU0hS0Hn4NVGtx_rTjVS2cGLlvfedMKvuROG_5mx5oKfuyuel2U6Cc_Bs62Ad1_G2APvTJCqbYVVbgycsJKQAjOcRfTpX-ilG72N7XGSYpZnRcFopJ5vKOldCF7pnRmM-DRwHgfOfw08sk9-d78jbyccgRcb4KuqnQ7SKCvVDkPxnQgjeZrGCOFIF_9PV2YQ03eo3GiHWHqwLTWtWv_bMl-cLDfefwKGHNcA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2514768843</pqid></control><display><type>article</type><title>Impact of diabetes on COVID‐19 and other infection: Report from the 22nd Hong Kong Diabetes and Cardiovascular Risk Factors—East Meets West Symposium</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>Web of Science - Science Citation Index Expanded - 2021&lt;img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /&gt;</source><creator>Luk, Andrea O. Y. ; Ng, Susanna S. S. ; Holt, Richard I. G.</creator><creatorcontrib>Luk, Andrea O. Y. ; Ng, Susanna S. S. ; Holt, Richard I. G.</creatorcontrib><description>The coronavirus disease 2019 (COVID‐19) pandemic has posed enormous challenges to healthcare systems worldwide. The negative impact of COVID‐19 is widespread and includes not only people who contracted the disease but also those with chronic morbidities such as diabetes whose care is compromised due to diversion of medical resources. People with diabetes are generally more susceptible to infection as a result of altered immunity. People with diabetes have a worse prognosis from COVID‐19 and there is evidence to suggest that severe acute respiratory syndrome coronavirus 2 may directly affect pancreatic function precipitating hyperglycaemic crises. In the United Kingdom, one of the most heavily affected countries, guidelines are in place to unify the management of people with diabetes hospitalized for COVID‐19. Diabetes services are re‐organized to ensure that medical care of people with diabetes is maintained despite resource and other practical constraints. Public health measures including social distancing, hand hygiene and the use of face masks are crucial in containing community transmission of the virus. Hong Kong, one of the most densely populated city in the world, is particularly vulnerable and has in place a stringent containment policy and aggressive contact tracing to ensure public safety during this pandemic.</description><identifier>ISSN: 0742-3071</identifier><identifier>EISSN: 1464-5491</identifier><identifier>DOI: 10.1111/dme.14547</identifier><identifier>PMID: 33615546</identifier><language>eng</language><publisher>HOBOKEN: Wiley</publisher><subject>Cardiovascular diseases ; Communicable Disease Control - methods ; Comorbidity ; Contact tracing ; Coronaviridae ; Coronaviruses ; COVID-19 ; COVID-19 - epidemiology ; COVID-19 - immunology ; COVID-19 - metabolism ; COVID-19 - therapy ; Delivery of Health Care - organization &amp; administration ; Diabetes ; Diabetes mellitus ; Diabetes Mellitus - epidemiology ; Diabetes Mellitus - immunology ; Diabetes Mellitus - metabolism ; Diabetes Mellitus - therapy ; Disease transmission ; Endocrinology &amp; Metabolism ; Glycemic Control ; Hand Hygiene ; Hong Kong - epidemiology ; Humans ; Hygiene ; Immunocompromised Host - immunology ; infection ; Infections - epidemiology ; Infections - immunology ; Influenza, Human - epidemiology ; Influenza, Human - immunology ; Life Sciences &amp; Biomedicine ; Masks ; Pancreas ; Pandemics ; Physical Distancing ; Practice Guidelines as Topic ; Public health ; Public Policy ; Review ; Reviews ; Risk ; Risk Factors ; SARS-CoV-2 ; Science &amp; Technology ; Severe acute respiratory syndrome ; Severe acute respiratory syndrome coronavirus 2 ; Severity of Illness Index ; United Kingdom - epidemiology</subject><ispartof>Diabetic medicine, 2021-05, Vol.38 (5), p.e14547-n/a</ispartof><rights>2021 Diabetes UK</rights><rights>2021 Diabetes UK.</rights><rights>Diabetic Medicine © 2021 Diabetes UK</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>1</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000624275500001</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c4437-55c08823dbf9bdf11e142fb0061004120012a0623447a8fcc71ff213348d8c9a3</citedby><cites>FETCH-LOGICAL-c4437-55c08823dbf9bdf11e142fb0061004120012a0623447a8fcc71ff213348d8c9a3</cites><orcidid>0000-0002-5244-6069 ; 0000-0001-8911-6744</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fdme.14547$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fdme.14547$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,315,782,786,887,1419,27931,27932,39265,45581,45582</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33615546$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Luk, Andrea O. Y.</creatorcontrib><creatorcontrib>Ng, Susanna S. S.</creatorcontrib><creatorcontrib>Holt, Richard I. G.</creatorcontrib><title>Impact of diabetes on COVID‐19 and other infection: Report from the 22nd Hong Kong Diabetes and Cardiovascular Risk Factors—East Meets West Symposium</title><title>Diabetic medicine</title><addtitle>DIABETIC MED</addtitle><addtitle>Diabet Med</addtitle><description>The coronavirus disease 2019 (COVID‐19) pandemic has posed enormous challenges to healthcare systems worldwide. The negative impact of COVID‐19 is widespread and includes not only people who contracted the disease but also those with chronic morbidities such as diabetes whose care is compromised due to diversion of medical resources. People with diabetes are generally more susceptible to infection as a result of altered immunity. People with diabetes have a worse prognosis from COVID‐19 and there is evidence to suggest that severe acute respiratory syndrome coronavirus 2 may directly affect pancreatic function precipitating hyperglycaemic crises. In the United Kingdom, one of the most heavily affected countries, guidelines are in place to unify the management of people with diabetes hospitalized for COVID‐19. Diabetes services are re‐organized to ensure that medical care of people with diabetes is maintained despite resource and other practical constraints. Public health measures including social distancing, hand hygiene and the use of face masks are crucial in containing community transmission of the virus. Hong Kong, one of the most densely populated city in the world, is particularly vulnerable and has in place a stringent containment policy and aggressive contact tracing to ensure public safety during this pandemic.</description><subject>Cardiovascular diseases</subject><subject>Communicable Disease Control - methods</subject><subject>Comorbidity</subject><subject>Contact tracing</subject><subject>Coronaviridae</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 - epidemiology</subject><subject>COVID-19 - immunology</subject><subject>COVID-19 - metabolism</subject><subject>COVID-19 - therapy</subject><subject>Delivery of Health Care - organization &amp; administration</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetes Mellitus - epidemiology</subject><subject>Diabetes Mellitus - immunology</subject><subject>Diabetes Mellitus - metabolism</subject><subject>Diabetes Mellitus - therapy</subject><subject>Disease transmission</subject><subject>Endocrinology &amp; Metabolism</subject><subject>Glycemic Control</subject><subject>Hand Hygiene</subject><subject>Hong Kong - epidemiology</subject><subject>Humans</subject><subject>Hygiene</subject><subject>Immunocompromised Host - immunology</subject><subject>infection</subject><subject>Infections - epidemiology</subject><subject>Infections - immunology</subject><subject>Influenza, Human - epidemiology</subject><subject>Influenza, Human - immunology</subject><subject>Life Sciences &amp; Biomedicine</subject><subject>Masks</subject><subject>Pancreas</subject><subject>Pandemics</subject><subject>Physical Distancing</subject><subject>Practice Guidelines as Topic</subject><subject>Public health</subject><subject>Public Policy</subject><subject>Review</subject><subject>Reviews</subject><subject>Risk</subject><subject>Risk Factors</subject><subject>SARS-CoV-2</subject><subject>Science &amp; Technology</subject><subject>Severe acute respiratory syndrome</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Severity of Illness Index</subject><subject>United Kingdom - epidemiology</subject><issn>0742-3071</issn><issn>1464-5491</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>HGBXW</sourceid><sourceid>EIF</sourceid><recordid>eNqNkstu1DAUhi0EosPAghdAltiAUFrfcmOBhDJTOqJVpXJbWo5jty6JHeykaHZ9BBZseL0-CQ4zHQESEl7YRzrf-f0fHwPwGKN9HNdB06l9zFKW3wEzzDKWpKzEd8EM5YwkFOV4DzwI4RIhTEpa3gd7lGY4TVk2Az9WXS_kAJ2GjRG1GlSAzsLq9ONqcXP9DZdQ2Aa64UJ5aKxWcjDOvoRnqnd-gNq7DsYcJCRSR86ew7fTtriVmoor4RvjrkSQYys8PDPhMzyMdzofbq6_L0UY4IlSQ4CfVAzfrbveBTN2D8E9LdqgHm3POfhwuHxfHSXHp29W1evjRDJG8yRNJSoKQptal3WjMVaYEV0jlGGEGCZT0wJlhDKWi0JLmWOtCaaUFU0hS0Hn4NVGtx_rTjVS2cGLlvfedMKvuROG_5mx5oKfuyuel2U6Cc_Bs62Ad1_G2APvTJCqbYVVbgycsJKQAjOcRfTpX-ilG72N7XGSYpZnRcFopJ5vKOldCF7pnRmM-DRwHgfOfw08sk9-d78jbyccgRcb4KuqnQ7SKCvVDkPxnQgjeZrGCOFIF_9PV2YQ03eo3GiHWHqwLTWtWv_bMl-cLDfefwKGHNcA</recordid><startdate>202105</startdate><enddate>202105</enddate><creator>Luk, Andrea O. Y.</creator><creator>Ng, Susanna S. S.</creator><creator>Holt, Richard I. G.</creator><general>Wiley</general><general>Wiley Subscription Services, Inc</general><general>John Wiley and Sons Inc</general><scope>BLEPL</scope><scope>DTL</scope><scope>HGBXW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5244-6069</orcidid><orcidid>https://orcid.org/0000-0001-8911-6744</orcidid></search><sort><creationdate>202105</creationdate><title>Impact of diabetes on COVID‐19 and other infection: Report from the 22nd Hong Kong Diabetes and Cardiovascular Risk Factors—East Meets West Symposium</title><author>Luk, Andrea O. Y. ; Ng, Susanna S. S. ; Holt, Richard I. G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4437-55c08823dbf9bdf11e142fb0061004120012a0623447a8fcc71ff213348d8c9a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Cardiovascular diseases</topic><topic>Communicable Disease Control - methods</topic><topic>Comorbidity</topic><topic>Contact tracing</topic><topic>Coronaviridae</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 - epidemiology</topic><topic>COVID-19 - immunology</topic><topic>COVID-19 - metabolism</topic><topic>COVID-19 - therapy</topic><topic>Delivery of Health Care - organization &amp; administration</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetes Mellitus - epidemiology</topic><topic>Diabetes Mellitus - immunology</topic><topic>Diabetes Mellitus - metabolism</topic><topic>Diabetes Mellitus - therapy</topic><topic>Disease transmission</topic><topic>Endocrinology &amp; Metabolism</topic><topic>Glycemic Control</topic><topic>Hand Hygiene</topic><topic>Hong Kong - epidemiology</topic><topic>Humans</topic><topic>Hygiene</topic><topic>Immunocompromised Host - immunology</topic><topic>infection</topic><topic>Infections - epidemiology</topic><topic>Infections - immunology</topic><topic>Influenza, Human - epidemiology</topic><topic>Influenza, Human - immunology</topic><topic>Life Sciences &amp; Biomedicine</topic><topic>Masks</topic><topic>Pancreas</topic><topic>Pandemics</topic><topic>Physical Distancing</topic><topic>Practice Guidelines as Topic</topic><topic>Public health</topic><topic>Public Policy</topic><topic>Review</topic><topic>Reviews</topic><topic>Risk</topic><topic>Risk Factors</topic><topic>SARS-CoV-2</topic><topic>Science &amp; Technology</topic><topic>Severe acute respiratory syndrome</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Severity of Illness Index</topic><topic>United Kingdom - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Luk, Andrea O. Y.</creatorcontrib><creatorcontrib>Ng, Susanna S. S.</creatorcontrib><creatorcontrib>Holt, Richard I. G.</creatorcontrib><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Web of Science - Science Citation Index Expanded - 2021</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Diabetic medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Luk, Andrea O. Y.</au><au>Ng, Susanna S. S.</au><au>Holt, Richard I. G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of diabetes on COVID‐19 and other infection: Report from the 22nd Hong Kong Diabetes and Cardiovascular Risk Factors—East Meets West Symposium</atitle><jtitle>Diabetic medicine</jtitle><stitle>DIABETIC MED</stitle><addtitle>Diabet Med</addtitle><date>2021-05</date><risdate>2021</risdate><volume>38</volume><issue>5</issue><spage>e14547</spage><epage>n/a</epage><pages>e14547-n/a</pages><issn>0742-3071</issn><eissn>1464-5491</eissn><abstract>The coronavirus disease 2019 (COVID‐19) pandemic has posed enormous challenges to healthcare systems worldwide. The negative impact of COVID‐19 is widespread and includes not only people who contracted the disease but also those with chronic morbidities such as diabetes whose care is compromised due to diversion of medical resources. People with diabetes are generally more susceptible to infection as a result of altered immunity. People with diabetes have a worse prognosis from COVID‐19 and there is evidence to suggest that severe acute respiratory syndrome coronavirus 2 may directly affect pancreatic function precipitating hyperglycaemic crises. In the United Kingdom, one of the most heavily affected countries, guidelines are in place to unify the management of people with diabetes hospitalized for COVID‐19. Diabetes services are re‐organized to ensure that medical care of people with diabetes is maintained despite resource and other practical constraints. Public health measures including social distancing, hand hygiene and the use of face masks are crucial in containing community transmission of the virus. Hong Kong, one of the most densely populated city in the world, is particularly vulnerable and has in place a stringent containment policy and aggressive contact tracing to ensure public safety during this pandemic.</abstract><cop>HOBOKEN</cop><pub>Wiley</pub><pmid>33615546</pmid><doi>10.1111/dme.14547</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-5244-6069</orcidid><orcidid>https://orcid.org/0000-0001-8911-6744</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0742-3071
ispartof Diabetic medicine, 2021-05, Vol.38 (5), p.e14547-n/a
issn 0742-3071
1464-5491
language eng
recordid cdi_pubmed_primary_33615546
source MEDLINE; Access via Wiley Online Library; Web of Science - Science Citation Index Expanded - 2021<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />
subjects Cardiovascular diseases
Communicable Disease Control - methods
Comorbidity
Contact tracing
Coronaviridae
Coronaviruses
COVID-19
COVID-19 - epidemiology
COVID-19 - immunology
COVID-19 - metabolism
COVID-19 - therapy
Delivery of Health Care - organization & administration
Diabetes
Diabetes mellitus
Diabetes Mellitus - epidemiology
Diabetes Mellitus - immunology
Diabetes Mellitus - metabolism
Diabetes Mellitus - therapy
Disease transmission
Endocrinology & Metabolism
Glycemic Control
Hand Hygiene
Hong Kong - epidemiology
Humans
Hygiene
Immunocompromised Host - immunology
infection
Infections - epidemiology
Infections - immunology
Influenza, Human - epidemiology
Influenza, Human - immunology
Life Sciences & Biomedicine
Masks
Pancreas
Pandemics
Physical Distancing
Practice Guidelines as Topic
Public health
Public Policy
Review
Reviews
Risk
Risk Factors
SARS-CoV-2
Science & Technology
Severe acute respiratory syndrome
Severe acute respiratory syndrome coronavirus 2
Severity of Illness Index
United Kingdom - epidemiology
title Impact of diabetes on COVID‐19 and other infection: Report from the 22nd Hong Kong Diabetes and Cardiovascular Risk Factors—East Meets West Symposium
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-09T13%3A04%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20diabetes%20on%20COVID%E2%80%9019%20and%20other%20infection:%20Report%20from%20the%2022nd%20Hong%20Kong%20Diabetes%20and%20Cardiovascular%20Risk%20Factors%E2%80%94East%20Meets%20West%20Symposium&rft.jtitle=Diabetic%20medicine&rft.au=Luk,%20Andrea%20O.%20Y.&rft.date=2021-05&rft.volume=38&rft.issue=5&rft.spage=e14547&rft.epage=n/a&rft.pages=e14547-n/a&rft.issn=0742-3071&rft.eissn=1464-5491&rft_id=info:doi/10.1111/dme.14547&rft_dat=%3Cproquest_pubme%3E2492281416%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2514768843&rft_id=info:pmid/33615546&rfr_iscdi=true